On May 9, 2024, CVS Health Corporation successfully issued and sold a series of Senior Notes totaling $5 billion. The offering included 5.400% Senior Notes due 2029, 5.550% Senior Notes due 2031, 5.700% Senior Notes due 2034, 6.000% Senior Notes due 2044, and 6.050% Senior Notes due 2054. This debt issuance was made under the company's Registration Statement on Form S-3ASR, initially filed on May 25, 2023. The Senior Notes are part of a broader agreement governed by a Senior Indenture dated August 15, 2006, between CVS Health and The Bank of New York Mellon Trust Company, N.A., as trustee. The company retains the option to issue additional senior debt securities under this agreement. The forms of the newly issued Notes have been filed with the SEC and are incorporated by reference into the Registration Statement.

On May 9, 2024, CVS Health Corporation successfully issued and sold a series of Senior Notes totaling $5 billion. The offering included 5.400% Senior Notes due 2029, 5.550% Senior Notes due 2031, 5.700% Senior Notes due 2034, 6.000% Senior Notes due 2044, and 6.050% Senior Notes due 2054. This debt issuance was made under the company's Registration Statement on Form S-3ASR, initially filed on May 25, 2023. The Senior Notes are part of a broader agreement governed by a Senior Indenture dated August 15, 2006, between CVS Health and The Bank of New York Mellon Trust Company, N.A., as trustee. The company retains the option to issue additional senior debt securities under this agreement. The forms of the newly issued Notes have been filed with the SEC and are incorporated by reference into the Registration Statement.